ArticlePloS one2025
Using the TSA-LSTM two-stage model to predict cancer incidence and mortality.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Intelligent Localization of Cross-Sectional Structural Damage in Molten Salt Receiver Tubes Using Mel Spectrograms and TSA-Optimized 2D-CNN.Sensors (Basel, Switzerland) · 2026Article
- The gastrin-releasing peptide receptor in oncology: a comprehensive review of recent advances in targeted radionuclide theranostics.Frontiers in oncology · 2026Review
- Exploring climate smart agriculture in Turkey: Enhancing food security and sustainable practices for the reduction of CO₂ emissions.PloS one · 2026Article
- PSOA-LSTM: a hybrid attention-based LSTM model optimized by particle swarm optimization for accurate lung cancer incidence forecasting in China (1990-2021).Frontiers in medicine · 2025Article
- Application and comparison of ARIMA, LSTM, and ARIMA-LSTM models for predicting foodborne diseases in Liaoning Province.Frontiers in big data · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer, the second-leading cause of mortality, kills 16% of people worldwide. Unhealthy lifestyles, smoking, alcohol abuse, obesity, and a lack of exercise have been linked to cancer incidence and mortality. However, it is hard. Cancer and lifestyle correlation analysis and cancer incidence and mortality prediction in the next several years are used to guide people's healthy lives and target medical financial resources. Two key research areas of this paper are Data preprocessing and sample expansion design Using experimental analysis and comparison, this study chooses the best cubic spline interpolation technology on the original data from 32 entry points to 420 entry points and converts annual data into monthly data to solve the problem of insufficient correlation analysis and prediction. Factor analysis is possible because data sources indicate changing factors. TSA-LSTM Two-stage attention design a popular tool with advanced visualization functions, Tableau, simplifies this paper's study. Tableau's testing findings indicate it cannot analyze and predict this paper's time series data. LSTM is utilized by the TSA-LSTM optimization model. By commencing with input feature attention, this model attention technique guarantees that the model encoder converges to a subset of input sequence features during the prediction of output sequence features. As a result, the model's natural learning trend and prediction quality are enhanced. The second step, time performance attention, maintains We can choose network features and improve forecasts based on real-time performance. Validating the data source with factor correlation analysis and trend prediction using the TSA-LSTM model Most cancers have overlapping risk factors, and excessive drinking, lack of exercise, and obesity can cause breast, colorectal, and colon cancer. A poor lifestyle directly promotes lung, laryngeal, and oral cancers, according to visual tests. Cancer incidence is expected to climb 18-21% between 2020 and 2025, according to 2021. Long-term projection accuracy is 98.96 percent, and smoking and obesity may be the main cancer causes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.